Senescent cells: a therapeutic target in cardiovascular diseases

M Suda, KH Paul, T Minamino, JD Miller, A Lerman… - Cells, 2023 - mdpi.com
Senescent cell accumulation has been observed in age-associated diseases including
cardiovascular diseases. Senescent cells lack proliferative capacity and secrete senescence …

New dawn for atherosclerosis: Vascular endothelial cell senescence and death

LL Bu, HH Yuan, LL Xie, MH Guo, DF Liao… - International journal of …, 2023 - mdpi.com
Endothelial cells (ECs) form the inner linings of blood vessels, and are directly exposed to
endogenous hazard signals and metabolites in the circulatory system. The senescence and …

Quercetin and dasatinib, two powerful senolytics in age-related cardiovascular disease

M Nieto, M Konigsberg, A Silva-Palacios - Biogerontology, 2024 - Springer
Cellular senescence is characteristic of the development and progression of multiple age-
associated diseases. Accumulation of senescent cells in the heart contributes to various age …

Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction

RE Redgrave, E Dookun, LK Booth… - npj Aging, 2023 - nature.com
Myocardial infarction is a leading cause of morbidity and mortality. While reperfusion is now
standard therapy, pathological remodelling leading to heart failure remains a clinical …

[HTML][HTML] A promising therapeutic peptide and preventive/diagnostic biomarker for age-related diseases: The Elabela/Apela/Toddler peptide

R Monastero, D Magro, M Venezia, C Pisano… - Ageing research …, 2023 - Elsevier
ABSTRACT Elabela (ELA), Apela or Toddler peptide is a hormone peptide belonging to the
adipokine group and a component of apelinergic system, discovered in 2013-2014. Given its …

Anti-ageing interventions for the treatment of cardiovascular disease

M Abdellatif, ST Schmid, A Fuerlinger… - Cardiovascular …, 2024 - academic.oup.com
As the global demographic landscape continues to shift towards an aged population, so
does the medical and socioeconomic burden of cardiovascular diseases. Indeed, ageing is …

Antisenescence therapy improves function in a human model of cardiac fibrosis-on-a-chip

O Mourad, O Mastikhina, S Khan, X Sun… - ACS Materials …, 2023 - ACS Publications
Cardiac fibrosis is a significant contributor to heart failure and is characterized by abnormal
ECM deposition and impaired contractile function. We have previously developed a model …

Cellular Senescence, Mitochondrial Dysfunction, and Their Link to Cardiovascular Disease

M Camacho-Encina, LK Booth, RE Redgrave… - Cells, 2024 - mdpi.com
Cardiovascular diseases (CVDs), a group of disorders affecting the heart or blood vessels,
are the primary cause of death worldwide, with an immense impact on patient quality of life …

Identification and functional analysis of senescent cells in the cardiovascular system using omics approaches

SA Mahoney, AK Dey, N Basisty… - American Journal of …, 2023 - journals.physiology.org
Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide, and
senescent cells have emerged as key contributors to its pathogenesis. Senescent cells …

The binding of HSPA8 and mitochondrial ALDH2 mediates oxygen-glucose deprivation-induced fibroblast senescence

W Hui, T Song, L Yu, X Chen - Antioxidants, 2023 - mdpi.com
Cellular senescence refers to the permanent and irreversible cessation of the cell cycle.
Recently, it has gained significant interest as a promising target for preventing …